Johnson Investment Counsel’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-5,403
Closed -$261K 564
2015
Q2
$261K Buy
5,403
+187
+4% +$7.88K 0.01% 470
2015
Q1
$226K Buy
+5,216
New +$187K 0.01% 498

Other funds holding PGEN

Johnson Investment Counsel's PGEN Position: Q3 2015 in Review

Johnson Investment Counsel sold out of Precigen (PGEN) in Q3 2015, closing a stake of 5,403 shares — an estimated $261K sold.

Johnson Investment Counsel first reported a position in PGEN in Q1 2015 and held it in 2 quarters. The position peaked at $261K in Q2 2015. 173 funds tracked by Wall St. Rank hold PGEN as of Q3 2015.

  • Johnson Investment Counsel reported no remaining Precigen position as of Q3 2015 after selling out during the quarter.
  • Johnson Investment Counsel sold 5,403 Precigen shares in Q3 2015, an estimated $261K.
  • Johnson Investment Counsel first reported a position in Precigen in Q1 2015 and held it in 2 quarters.
  • Johnson Investment Counsel's Precigen position peaked at $261K in Q2 2015.
  • 173 funds tracked by Wall St. Rank held Precigen as of Q3 2015.

Based on Johnson Investment Counsel's 13F filing for Q3 2015, filed 16 Nov 2015.